The global central venous
catheter market size was valued at US$ 1,167.4 million in 2017, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 - 2026).
[ClickPress, Mon Aug 05 2019] This report on the Global Venous
Stents Market analyzes the current and future scenario of the global market.
access is frequently done in any critical care units with multiple indications and assessment of central venous
pressure (CVP) in critically ill patients is considered as keystone of management1,2.
The pathophysiological mechanism of CVI and VVs consists mainly in alteration of venous
return, triggered by the incompetence of venous
valves or by an intrinsic defect of the vein wall.
Medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX) reported on Thursday the receipt of the US Food and Drug Administration's premarket approval for the Venovo venous
stent for the treatment of iliofemoral venous
hemorrhage is uncommon and when traumatic, has mortality rates above 50% (1).
1, 2018 (HealthDay News) -- The risk of recurrence after incident venous
thromboembolism is high, particularly among patients with cancer-related venous
thromboembolism, according to a study published in the September issue of The American Journal of Medicine.
Boston Scientific has signed an agreement to acquire VENITI Inc., a privately-held company in Fremont, Calif., that has developed and commercialized the VICI Venous
Stent System for treating venous
Objective: To assess normal venous
anatomy of the cranium and its anatomical variants.
The vertebral venous
plexus (VVP) is also known as the epidural venous
plexus, longitudinal spinal veins, vertebral sinuses (Caballero et al., 2012) or Batson's plexus (Junquera et al., 2004).
leg ulcers are the most serious type of chronic venous